To find the cause of the extremely high levels of LDH activity, we measured serum LDH after removal of Ig fractions.2 With this treatment, the LDH level was dramatically decreased to normal values. Enzyme immunoelectrophoresis revealed LDH bands which reacted with anti-IgA and K-chain antiserum.
never exceeding two or three times normal values.' We report here the first case of a patient with a lactate dehydrogenase (LDH) anomaly and extremely high LDH levels.
A 7 1-year-old woman was admitted to our hospital because of a markedly elevated serum LDH level. She had suffered from mild essential hypertension and had been treated with oral antihypertensive drugs since 1990. On physical examinations, she appeared healthy and her blood pressure was well controlled. Laboratory examinations revealed that serum levels of haemoglobin, liver transaminase and creatine kinase were within normal ranges and that she did not have dysgammaglobulinaemia. However, a marked elevation of serum LDH level (reaching 3350 U/1, especially in LDH3-5 fractions) was confirmed. A computed tomographic scan of the chest, abdomen and pelvis showed no abnormality, and endoscopic gastrointestinal examination and sigmoidoscopy revealed no evidence of malignancy. Wholebody 67Ga-scintigraphy did not detect any abnormalities.
To find the cause of the extremely high levels of LDH activity, we measured serum LDH after removal of Ig fractions.2 With this treatment, the LDH level was dramatically decreased to normal values. Enzyme immunoelectrophoresis revealed LDH bands which reacted with anti-IgA and K-chain antiserum.
In conclusion, we should always keep in mind the possibility of an LDH anomaly in healthy patients when the LDH level does not seem to be related to the clinical state, even if the level is extremely high. Arterial re-bleed following tPA administration Sir, Two patients were recently admitted on to our Coronary Care Unit (CCU). The first, a 67-year-old woman, suffered from a ventricular fibrillation. She arrested shortly after admission and had electrocardiographic (ECG) changes suggestive of an anteriolateral myocardial infarction. During the arrest arterial blood gases were taken from the radial artery of the left arm. Once stabilised, the decision was taken to thrombolyse the patient, and after an adverse reaction with streptokinase, tissue plasminogen activator (tPA) was given, followed by 24 hours of intravenous heparin, successfully re-vascularising the heart. However, 24 hours post-thrombolysis she complained of a painful, swollen left forearm, which was diagnosed as compartment syndrome secondary to a re-bleed of the arterial blood gas site. She required urgent surgical decompression. The second patient, a 78-year-old man was transferred from an acute medical ward to the CCU and had an electromechanical dissociation arrest whilst on the unit, during which arterial blood gases were taken from the left femoral artery. He was thrombolysed with tPA, followed by intravenous heparin for 24 hours, as his ECG showed changes consistent with a myocardial infarction. The following day he complained of bruising and pain in his left thigh at the site of the arterial stab, which on examination revealed a large haematoma secondary to a femoral artery re-bleed. This resolved with conservative management and was scanned with ultrasound to rule out the possibility of a false aneurysm formation.
In both of these cases, the arterial blood gas sites were adequately compressed and no bleeding was noted. However, after thrombolysis with tPA and anticoagulation with heparin, the wounds re-bled, in one case with serious consequences, requiring surgery.
Re-bleed from streptokinase thrombolysis has been reported in the literature, however, we could find no reference to tPA re-bleed post-thrombolysis. We 
